Urol. praxi. 2026;27(1):37-41 | DOI: 10.36290/uro.2025.055

The influence of lifestyle on the prevention and treatment of benign prostatic hyperplasia from a pharmacist's perspective

Mgr. Ondřej Šimandl

EUC Lékárna, Poliklinika Malešice, Praha

Ústav farmakologie, 2. lékařská fakulta Univerzity Karlovy, Praha

Benign prostatic hyperplasia is one of the most common non-malignant diseases affecting middle-aged and older men. In addition to pharmacological treatment and surgical options, lifestyle and dietary measures also play an increasingly important role, both in the prevention and supportive treatment of this disease. The article offers a view of the issue of benign prostatic hyperplasia from the perspective of a pharmacist, who, among other things, has an irreplaceable role in educating patients and supporting adherence to treatment. Attention is paid in particular to the influence of diet, physical activity, limiting alcohol consumption and non-smoking, reducing stress and maintaining optimal body weight. The article also includes an overview of basic drugs indicated in the therapy of benign prostatic hyperplasia, including a reminder of the principles of their proper use, and a warning about groups of drugs that may worsen the symptoms of this disease. The aim of the article is also to point out the importance of an interdisciplinary approach in which the pharmacist actively contributes to improving the quality of life of patients through advice not only in the field of pharmacotherapy, but also through the promotion of a healthy lifestyle.

Keywords: benign prostatic hyperplasia, prevention, lifestyle, pharmacotherapy, regimen measures.

Received: July 31, 2025; Revised: July 31, 2025; Accepted: August 11, 2025; Published: March 16, 2026  Show citation